Kawamoto Jun, Kurihara Tatsuo
Institute for Chemical Research, Kyoto University, Uji, Kyoto, Japan.
Methods Mol Biol. 2022;2414:191-205. doi: 10.1007/978-1-0716-1900-1_12.
Extracellular membrane vesicles (EMVs) produced by Gram-negative bacteria are useful as a vaccine platform. During growth in broth at 18 °C, Shewanella vesiculosa HM13 produces a large number of EMVs that contain a 49-kDa major cargo protein, named P49. Enhanced green fluorescent protein fused to the C-terminus of P49 is delivered to EMVs, suggesting that P49 is useful as a carrier to target foreign proteins to EMVs for production of artificial EMVs with desired functions. This method is potentially useful for the preparation of designed vaccines and is described in detail in this chapter.
革兰氏阴性菌产生的细胞外膜泡(EMV)可作为一种疫苗平台。在18℃肉汤中生长时,水泡希瓦氏菌HM13会产生大量含有一种名为P49的49 kDa主要载脂蛋白的EMV。与P49 C端融合的增强型绿色荧光蛋白被递送至EMV,这表明P49可作为一种载体,将外源蛋白靶向至EMV,以生产具有所需功能的人工EMV。该方法在设计疫苗的制备中具有潜在用途,本章将对此进行详细描述。